Table A1.
Univariable Analyses of Prognostic Factors and ColDx Score (n = 393)
| Factor | Percent High Risk* | P† |
|---|---|---|
| Age (mean age; high v low risk) | 64 v 63 years | .43 |
| Sex (male v female) | 57% v 49% | .003 |
| Race (white v other) | 52% v 73% | < .001 |
| Treatment (edrecolomab v observation) | 53% v 54% | .66 |
| T stage (T4 v T3) | 65% v 53% | .04 |
| Nodes examined (mean No. of nodes; high v low risk) | 14 v 14 nodes | .89 |
| Perineural invasion (absent v present) | 53% v 60% | .46 |
| Lymphovascular invasion (absent v present) | 52% v 63% | .01 |
| Tumor grade (high v low) | 53% v 53% | .95 |
| Tumor location (proximal v distal) | 51% v 57% | .03 |
| Obstruction perforation (absent v present) | 53% v 67% | .17 |
| MMR (deficient v intact) | 45% v 56% | < .001 |
Abbreviation: MMR, mismatch repair.
*
Except for continuous variables age and number of nodes examined, where means are given.
†
χ2 test except for continuous variables, where the t test was used.